Citation Impact

Citing Papers

Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Suppression of Aging in Mice by the Hormone Klotho
2005 StandoutScience
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Tumour-cell invasion and migration: diversity and escape mechanisms
2003 Standout
Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP.
2003
Untangling the ErbB signalling network
2001 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
High-Resolution Analysis of DNA Copy Number Using Oligonucleotide Microarrays
2004
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
The insulin-like growth factor system and cancer
2003
Cancer chemoprevention with dietary phytochemicals
2003 Standout
Mechanotransduction in Development
2011
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
2005 StandoutNature
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Cellular senescence: when bad things happen to good cells
2007 Standout
Determination of subcutaneous tumor size in athymic (nude) mice
1989 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Integrated Proteomic and Glycoproteomic Analyses of Prostate Cancer Cells Reveal Glycoprotein Alteration in Protein Abundance and Glycosylation*
2015
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Technical considerations for studying cancer metastasis in vivo
1997
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Selective Reporting Biases in Cancer Prognostic Factor Studies
2005
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
The biology and function of fibroblasts in cancer
2016 Standout
The ground state of embryonic stem cell self-renewal
2008 StandoutNature
Celastrols as Inducers of the Heat Shock Response and Cytoprotection
2004 Standout
Natural and pharmacological regulation of telomerase
2002
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents
2000
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
The golden age: gold nanoparticles for biomedicine
2011 Standout
Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer
2001
Regulation of prostatic growth and function by peptide growth factors
1996
Essential Role for G Protein-coupled Receptor Endocytosis in the Activation of Mitogen-activated Protein Kinase
1998 StandoutNobel
Signaling—2000 and Beyond
2000 Standout
Cytogenetic studies in prostate cancer: Are we making progress?
1997
Self-consumption: the interplay of autophagy and apoptosis
2014 Standout
Fibroblasts as architects of cancer pathogenesis
2012
A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
1999
Gold nanorods and their plasmonic properties
2012 Standout
The ?6?1 and ?6?4 integrins in human prostate cancer progression
1995
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells
2005
Mechanisms of Bone Metastasis
2004 Standout
DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions
2012
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
1997
Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications
2009 Standout
p53 Mutation and Locoregional Treatment Failure in Head and Neck Squamous Cell Carcinoma
1996
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy
2004
Head and Neck Cancer
2001 Standout
The RASSF proteins in cancer; from epigenetic silencing to functional characterization
2009
Efficacy of Laser-Activated Gold Nanoshells in Ablating Prostate Cancer Cells in Vitro
2007
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Biosensing with plasmonic nanosensors
2008 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
The androgen receptor A mediator of diverse responses
1996
Hijacking the Chromatin Remodeling Machinery: Impact ofSWI/SNFPerturbations in Cancer
2009
A contractile and counterbalancing adhesion system controls the 3D shape of crawling cells
2014 StandoutNobel
Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin.
1996
CCR5-Dependent Homing of T Regulatory Cells to the Tumor Microenvironment Contributes to Skin Squamous Cell Carcinoma Development
2017
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
2001
Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.
2002
eFGF and its mode of action in the community effect during Xenopus myogenesis
2001 StandoutNobel
HER‐2 profiling and targeting in prostate carcinoma
2002
Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with Inhibitors
1997 Science
Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer
2004
Androgen-repressed phenotype in human prostate cancer
1996
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
2000 StandoutScience
Hoxb13is required for normal differentiation and secretory function of the ventral prostate
2003 StandoutNobel
Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice
2000
Targeted gold nanorod contrast agent for prostate cancer detection by photoacoustic imaging
2007
Insulin-like Growth Factor-I–Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
2008
A strategy to discover circulating angiogenesis inhibitors generated by human tumors.
1995
Differential Regulation of the Mitogen-Activated Protein and Stress-Activated Protein Kinase Cascades by Adrenergic Agonists in Quiescent and Regenerating Adult Rat Hepatocytes
1997
The Gene Expression Program of Prostate Fibroblast Senescence Modulates Neoplastic Epithelial Cell Proliferation through Paracrine Mechanisms
2006
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms.
1995
Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
1998
Chemical Glycoproteomics
2016 StandoutNobel
Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3
2011

Works of Joy L. Ware being referenced

Amplification and overexpression of prosaposin in prostate cancer
2005
A novel tumorigenic human prostate epithelial cell line (M2205)
2003
Mesenchymal stem cells in mammary adipose tissue stimulate progression of breast cancer resembling the basal-type
2012
Workgroup 2: Human xenograft models of prostate cancer
1998
Isolation and characterization of transforming growth factor beta response variants from human prostatic tumor cell lines
1992
Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer
1993
Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line
1998
Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15
1996
Metastatic Diversity in Human Prostatic Carcinoma: Implications of Growth Factors and Growth Factor Receptors for the Metastatic Phenotype
1989
p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx
1994
Genome-wide detection of LOH in prostate cancer using human SNP microarray technology
2003
Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents
2010
Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate
1991
Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression
1994
Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell‐mediated restoration of chromosome 19
2001
Identification of a Novel Cell Death Receptor Mediating IGFBP-3-induced Anti-tumor Effects in Breast and Prostate Cancer
2010
Inhibition of vimentin or β1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo
2009
Prostate cancer progression. Implications of histopathology.
1994
A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression.
2001
Influence of tumour size on human prostate tumour metastasis in athymic nude mice
1985
Factors Influencing Phenotypic Diversity of Human Prostate Carcinoma Cells Metastasizing in Athymic Nude Mice
1985
The Effect of Hyperthermia on Human Prostatic Carcinoma Cell Lines: Evaluation in Vitro
1989
Transcriptional Regulation of Insulin-Like Growth Factor-I Receptor Gene Expression in Prostate Cancer Cells**This work was supported by V.A. Merit Review Program (to S.R.P.), DAMD 17–98-1–8540 (to J.L.W.), NIH DK-52683 (to S.R.P. and J.L.W.), and NIH DK-50810 (to C.T.R.). The content of this report does not necessarily represent the position or the policy of the United States government, and no official endorsement should be inferred.
2001
Rankless by CCL
2026